Q: Any reason for the decline . Would you be a buyer at these levels?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: PLI made a,nice move today. My cost is 1.98. Should i sell?
Q: Hi guys,
I already own PLI (3%) and I purchased BLUE. US last year around $70.00. I sold BLUE in September around $ 105 (happy but now NOT). Your thoughts about getting back in (1%).
Thanks,
Jim
I already own PLI (3%) and I purchased BLUE. US last year around $70.00. I sold BLUE in September around $ 105 (happy but now NOT). Your thoughts about getting back in (1%).
Thanks,
Jim
Q: is there a good etf of cannabis stocks that you would recommend, regards from tom in kelowna
Q: GUD How is Jonathan Goodman's health. What is his age ? Does he have good people around him or does he make all the decisions ? Any insider buying ? RAK
Q: Cipher is improving and the stock is trending up. With that being said, Knight looks better for the long term if they ever deploy their cash hoard. I currently have a half position in Cipher where a tax loss can be harvested. Take the tax loss and top up my position in Knight while it's down?
Thanks!
Thanks!
-
Chartwell Retirement Residences (CSH.UN $20.25)
-
iShares Core Canadian Corporate Bond Index ETF (XCB $20.05)
Q: I have to sell some of my shares in my registered LIF Account by the end of the year. Which of the two mentioned above should I lighten up on. XCB looks flat and has only a small dividend. I would prefer to keep my CSH.UN for long term.
What is your opinion and reasoning.
Thank you!
What is your opinion and reasoning.
Thank you!
Q: Can you please provide your analysis of Celgene. I have not yet invested in a biopharmaceutical company and need some help with investment decision. Do you like this area? What is the future growth opportunity, and projected valuation over next 2-3 years? Thank you!
Q: Hi there, I noticed a recent answer where you recommended COV and GUD for a growth and balanced healthcare name. I know it may be best to split a position in two and own both names, but if you had to buy just one which would it be - for short term (1-2 years) or long term (5-10 years)? Thanks!
Q: TEKLA LIFE SCIENCE - Hello Peter, I am underweight in HeALTHCARE and thinking of HQL. Has good distribution. Would you endorse it or suggest an alternative. thanks
Q: Hi Peter,
I've been watching this closely since it was first recommended. It's now back to the low $4's and is looking quite attractive.
Before I pull the trigger and jump in, can you remind me of the positive attributes and potential long term earnings potential? If you were to give me a best 3-5 year price target 'guesstimate' assuming things work out with the company, what might that look like?
I've been watching this closely since it was first recommended. It's now back to the low $4's and is looking quite attractive.
Before I pull the trigger and jump in, can you remind me of the positive attributes and potential long term earnings potential? If you were to give me a best 3-5 year price target 'guesstimate' assuming things work out with the company, what might that look like?
Q: GUD. At the end of the day, the stock is still pretty low ($7.56). Would you advise letting it run, and await better stock price ? I bought the stock at $10.15. Will it come back at that price, with patience ?
Q: I have a question about two companies.
11.6% of XX shares were acquired by Campbell at 39.5 cents. The stock was halted and it dropped after the halt was removed to around 33 cents. Do you think there is something cooking or it is just pure speculation. Would you recommend buying If already owned.
CHH dropped a lot due to CEO resignation and the shares dropped. I already had some shares at 63 cents and I bought more at 53. Is this a good company for one year time frame. Thanks
11.6% of XX shares were acquired by Campbell at 39.5 cents. The stock was halted and it dropped after the halt was removed to around 33 cents. Do you think there is something cooking or it is just pure speculation. Would you recommend buying If already owned.
CHH dropped a lot due to CEO resignation and the shares dropped. I already had some shares at 63 cents and I bought more at 53. Is this a good company for one year time frame. Thanks
Q: Hello,
Any thoughts about Charles River Labs? Why did the stock drop in the last month?
Thanks!
Derek
Any thoughts about Charles River Labs? Why did the stock drop in the last month?
Thanks!
Derek
Q: Is this a decent tax loss candidate for purchase?
Q: Rht has had a very big move lately. It appears they are adding about 2000 patients per month, 6000 total by 2017 year end and 30000 2018. I listened to the conference call and found it very compelling on all fronts. Can you take a new look at it please.
Regards
Regards
Q: Any view on this one?
Q: Your outlook on EXE please. Do you like it, would you add new money today.
Q: my pharma bio is very thin Savaria in Canada and Pfizer inU.S.
However I am hesitant to add holdings.
does switching out of Pfizer to Wallgreen (a top pic recentlyin BNN )or J&J add value
However I am hesitant to add holdings.
does switching out of Pfizer to Wallgreen (a top pic recentlyin BNN )or J&J add value
Q: Greetings 5i,
VRX seems to have rallied since it reported. Mgt looks to be doing a good job in reducing debt and providing transparency. They also offered notes I believe mid November reducing near term debt. I know you are cautious re: VRX however what additionally would be needed to endorse this company? It seems to be racing away as we sit and hope for more improvements.
Cheers!
VRX seems to have rallied since it reported. Mgt looks to be doing a good job in reducing debt and providing transparency. They also offered notes I believe mid November reducing near term debt. I know you are cautious re: VRX however what additionally would be needed to endorse this company? It seems to be racing away as we sit and hope for more improvements.
Cheers!